Pyatoykina AS, Zhilyaeva TV, Semennov IV, Mishanov GA, Blagonravova AS, Mazo GE
Argenta, P
Post-hoc analyses from clinical trials show tirzepatide may reduce high-sensitivity C-reactive protein (hsCRP) levels, though reductions appear to correlate with weight loss and improved glycemic control
The good news is that this may mean a new approach to prevent or treat heart disease, the most obvious of which would be to limit dietary choline intake. But, if that means decreasing egg, meat, and dairy consumption, then the new approach sounds an awful lot like the old approach
Many patients notice improvements in sleep and energy within the first few weeks, with continued benefits developing over several months